Understanding Psoriasis: A Holistic Examination of A Complex Cutaneous Disorder
Keywords:
Psoriasis, Corticosteroids, Autoimmune Skin Disorder, Vitamin D analogues, Novel drug delivery (NDD)Abstract
Millions of people worldwide suffer with psoriasis, a chronic inflammatory skin illness caused by the immune system that is typified by erythematous plaques covered in silvery scales. The current understanding of psoriasis, including its etiology, pathophysiology, clinical symptoms, and therapeutic options, is thoroughly examined in this study. Psoriasis is caused by a complex interaction of immune system dysregulation, environmental stressors, and genetic predisposition. Numerous susceptibility loci have been found through genome-wide association studies, underscoring the disease's polygenic origin. Immunologically, the Th17/IL-23 axis in particular, as well as the dysregulation of T cells, dendritic cells, and cytokines, are key factors in initiating the inflammatory cascade. Psoriasis can present clinically as a variety of morphologies, from isolated plaques to extensive skin and nail involvement. Beyond just skin-related symptoms, the effects also negatively impact quality of life and raise the possibility of comorbid conditions such as psoriatic arthritis, cardiovascular disease, and psychological disorders. A multifaceted strategy that takes into account the patient's preferences, comorbidities, and the severity of the condition is included in treatment techniques. Systemic treatments like methotrexate, cyclosporine, and biologics are saved for severe or refractory cases, whereas topical therapy including corticosteroids, vitamin D analogues, and calcineurin inhibitors are frequently used for mild to moderate illness. Promising opportunities exist for the future of psoriasis treatment thanks to newly developed treatments that target fresh pathways. Research is being conducted on small molecule inhibitors, cytokine-targeted therapeutics, and gene-based strategies with the goal of meeting unmet needs and enhancing treatment results. Even with the progress made in therapeutics, there are still issues with maximizing effectiveness, reducing side effects, and guaranteeing long-term illness control. The complexity of psoriasis is highlighted in this review, along with the significance of continuing research efforts to identify its pathophysiology and create novel therapeutic approaches that will improve the quality of life for those who suffer from this crippling ailment. This review aims to provide readers with a comprehensive understanding of psoriasis through an examination of its genesis, pathophysiology, clinical manifestations, accessible therapies, and recent advancements in the area. By examining the intricate mechanisms that underpin this disorder, we hope to shed light on the most recent advancements in its treatment and offer suggestions for future directions in both study and therapy
Downloads
Metrics
References
Whan B Kim, Dana Jerome et.al. “Diagnosis & Management of psoriasis”. Canadian Family Physician. Vol 63, April 2017. 278-285 [Diagnosis and management of psoriasis | The College of Family Physicians of Canada (cfp.ca)].
Koji Kamiya et.al “Risk Factors for the Development of Psoriasis”. International Journal of Molecular Sciences. Int. J. Mol. Sci. 2019, 20, 4347; [doi:10.3390/ijms20184347]
Armstrong, A. W., & Read, C. (2020). Pathophysiology, clinical presentation, and treatment of psoriasis: A review. JAMA, 323(19), 1945-1960. doi:10.1001/jama.2020.4006
Jilang Li et.al. “Pulsatilla saponin inhibits the proliferation of keratinocytes and ameliorates imiquimod-induced psoriasis through the NF-κB and STAT3 signaling pathways”. Journal of Traditional and Complementary Medicine.2024 [https://doi.org/10.1016/j.jtcme.2024.04.001]
Veronica Di Nardo et.al. “Is there any place for Local Natural Treatment for Psoriasis”. Macedonian Journal of Medical Sciences. Vol. 6(5). 839-842. eISSN:1857 9655. [https://doi.org/10.3889/oamjms.2018.106]
R.K. Maicon et.al. “Healing effect of Dillenia indica fruit extracts standardized to botulinic acid on ultraviolet radiation-induced psoriasis-like wounds in rats”. Pharmaceutical Biology, 2017. VOL. 55, NO. 1, 641–648. [http://dx.doi.org/10.1080/13880209.2016.1266672]
Salunke AS, Nagargoje MV, Belgaumkar VA, Tolat SN, Chavan RB. Association of metabolic syndrome in chronic plaque psoriasis patients and their correlation with disease severity, duration and age: A case control study from western Maharashtra. J Clin Diagn Res. 2017;11: WC06–WC10. [PubMed] [Google Scholar]
Girisha BS, Thomas N. Metabolic syndrome in psoriasis among urban south Indians: A case control study using SAM- NCEP criteria. J Clin Diagn Res. 2017;11: WC01–04. [PubMed] [Google Scholar]
Rajesh D, Gurumurthy R, Kutty AV, Balakrishna S. Tumor necrosis factor alpha gene promoter- 238G/A polymorphism increases the risk of psoriasis vulgaris in Indian patients. Int J Dermatol. 2017; 56:307–11. [PubMed] [Google Scholar]
Narayanasamy K, Sanmarkan AD, Rajendran K, Annasamy C, Ramalingam S. Relationship between psoriasis and non-alcoholic fatty liver disease. Prz Gastroenterol. 2016; 11:263–9. [PMC free article] [PubMed] [Google Scholar]
Kothiwale SK, Khanna N, Tandon N, Naik N, Sharma VK, Sharma S, et al. Prevalence of metabolic syndrome and cardiovascular changes in patients with chronic plaque psoriasis and their correlation with disease severity: A hospital-based cross-sectional study. Indian J Dermatol Venereol Leprol. 2016; 82:510–8. [PubMed] [Google Scholar]
Indhumathi S, Rajappa M, Chandrashekar L, Ananthanarayanan PH, Thappa DM, Negi VS, et al. T helper-2 cytokine/regulatory T-cell gene polymorphisms and their relation with risk of psoriasis in a South Indian Tamil cohort. Hum Immunol. 2017; 78:209–15. [PubMed] [Google Scholar]
Krisztina Bodnár et.al. “Recent Approaches for the Topical Treatment of Psoriasis Using Nanoparticles”. Pharmaceutics 2024, 16, 449. [https://doi.org/10.3390/pharmaceutics16040449].
Krunal K. Detholia. “Innovative Approaches in Psoriasis Management: Integration of Novel Drug Delivery Systems, Herbal Medicine, and Lifestyle Modifications”. International Journal of Scientific Research in Engineering and Management (IJSREM). Volume: 08 Issue: 07 | July - 2024. [DOI: 10.55041/IJSREM36650].
Patel P, Shah D, Bambharoliya T, Patel V, Patel M, Patel D, et al. A Review on the Development of Novel Heterocycles as α-Glucosidase Inhibitors for the Treatment of Type-2 Diabetes Mellitus. Medicinal Chemistry. 2024;20(5):503–36.
Shah U, Shah A, Patel S, Patel A, Patel M, Solanki N, et al. Atorvastatin’s Reduction of Alzheimer’s Disease and Possible Alteration of Cognitive Function in Midlife as well as its Treatment. CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS & Neurological Disorders). 2023;22(10):1462– 71.
Vashi A. cell-based in vitro models: emerging technologies for enhanced drug permeability prediction. International Research Journal of Modernization in Engineering Technology and Science. 2024;6(04):6389–97.
Patel BA. Noisome: a promising approach for advanced drug delivery in cancer treatment. International Research Journal of Modernization in Engineering Technology and Science. 2024;6(04):2747–52.
Li Z, Lu J, Ou J, Yu J, Lu C. Effect of Chinese herbal medicine injections for treatment of psoriasis vulgaris: a systematic review and meta-analysis. Frontiers in Pharmacology. 2023 Jul 3; 14:1148445.
Bader A, Martini F, Schinella GR, Rios JL, Prieto JM. Modulation of Cox‐1, 5‐, 12‐and 15‐Lox by Popular Herbal Remedies Used in Southern Italy Against Psoriasis and Other Skin Diseases. Phytotherapy Research. 2015 Jan;29(1):108-13.
Vashi AS. renewable resource-based polymers and properties of interpenetrating polymer networks based on castor oil. International Research Journal of Modernization in Engineering Technology and Science. 2024;6(04):7074–9. International Journal of Scientific Research in Engineering and Management (IJSREM) Volume: 08 Issue: 07 | July - 2024 SJIF Rating: 8.448 ISSN: 2582-3930 © 2024, IJSREM | www.ijsrem.com DOI: 10.55041/IJSREM36650 | Page 8.
Jo HG, Kim H, Lee D. Oral administration of East Asian herbal medicine for inflammatory skin lesions in plaque psoriasis: a systematic review, meta-analysis, and exploration of core herbal materials. Nutrients. 2022 Jun 12;14(12):2434.
Chauhan NN, Jadeja MB, Shah BN, Saluja ak. study of in-vitro anti-oxidant activity of stem of samanea saman. Pharma Science Monitor. 2020;11(1).
Tsou WH, Heinrich M, Booker A. Chinese and western herbal medicines for the topical treatment of psoriasis– a critical review of efficacy and safety. Journal of Herbal Medicine. 2022 Jul 1; 34:100579.
Kasemnitichok Y, Chaijaroenkul W, Na-Banchan K. Herbal medicine for psoriasis and their molecular targets: A systematic review. African Journal of Pharmacy and Pharmacology. 2022 Mar 31;16(3):27-52.
Downloads
Published
How to Cite
Issue
Section
License

This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
Terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.